Nutritional consequences of small intestinal bacterial overgrowth

Practical Gastroenterology

Volumn 32, Issue 12, 2008, Pages 15-28

  DiBaise, John K ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFALEXIN; CHLORAMPHENICOL; CHLORTETRACYCLINE; CIPROFLOXACIN; COTRIMOXAZOLE; DOXYCYCLINE; METRONIDAZOLE; NEOMYCIN; NORFLOXACIN; PREBIOTIC AGENT; PROBIOTIC AGENT; PROKINETIC AGENT; RIFAXIMIN; TETRACYCLINE;

ACUTE PANCREATITIS; ALLERGIC REACTION; ARTICLE; BACTERIAL COLONIZATION; CELIAC DISEASE; CHRONIC PANCREATITIS; CLINICAL FEATURE; CLINICAL TRIAL; CULTURE TECHNIQUE; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIARRHEA; DISEASE PREDISPOSITION; DRUG EFFICACY; DRUG REEXPOSURE; ENTERITIS; GASTROINTESTINAL SYMPTOM; HIGH RISK PATIENT; HUMAN; HYDROGEN BREATH TEST; ILEOCECAL VALVE; IMMUNE DEFICIENCY; INTESTINAL DYSMOTILITY; INTESTINE BIOPSY; INTESTINE ENDOSCOPY; INTESTINE FLORA; IRRITABLE COLON; KIDNEY FAILURE; LIVER FAILURE; LOW FAT DIET; MALABSORPTION; NON INVASIVE MEASUREMENT; NUTRITIONAL DEFICIENCY; PATHOPHYSIOLOGY; RADIATION ENTEROPATHY; RISK ASSESSMENT; RISK FACTOR; SHORT BOWEL SYNDROME; SMALL INTESTINE BACTERIAL OVERGROWTH; SMALL INTESTINE DISEASE; STOMACH ACID SECRETION; TREATMENT INDICATION; ULCERATIVE COLITIS;

EID: 58349088969     PISSN: 02774208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (74)

1. Corazza GR, Menozzi MG, Strocchi A, et al. The diagnosis of small bowel bacterial overgrowth. Reliability of jejunal culture and inadequacy of breath hydrogen testing. Gastroenterology, 1990;98:302-309.
2. Kohler H, McCormick BA, Walker WA. Bacterial-enterocyte crosstalk: cellular mechanisms in health and disease. J Pediatr Gastroenterol Nutr, 2003;36:175-185.
3. Jorgensen JR, Fitch MD, Mortensen PB, Fleming SE. In vivo absorption of medium-chain fatty acids by the rat colon exceeds that of short-chain fatty acids. Gastroenterology, 2001;120:1152-1161.
4. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature, 2006;444:1022-1023.
5. DiBaise JK, Zhang H, Crowell MD, et al. Gut microbiota and its possible relationship to obesity. Mayo Clin Proc, 2008;83:460-469.
6. Gorbach SL. Probiotics and gastrointestinal health. Am J Gastroenterol, 2000;95:S2-S4.
7. Kaufman SS, Loseke CA, Lupo JV, et al. Influence of bacterial overgrowth and intestinal inflammation on duration of parenteral nutrition in children with short bowel syndrome. J Pediatr, 1997;131:356-361.
8. Ament ME, Shimoda SS, Saunders DR, Rubin CE. Pathogenesis of steatorrhea in three cases of small intestinal stasis syndrome. Gastroenterology, 1972;63:728-747.
9. Toskes PP, Giannella RA, Jervis HR, et al. Small intestinal mucosal injury in the experimental blind loop syndrome. Light-and electron-microscopic and histochemical studies. Gastroenterology, 1975;68:193-203.
10. Riordan SM, McIver CJ, Wakefield D, et al. Small intestinal bacterial overgrowth in the symptomatic elderly. Am J Gastroenterol, 1997;92:47-51.
11. Riepe SP, Goldstein J, Alpers DH. Effect of secreted Bacteroides proteases on human intestinal brush border hydrolases. J Clin Invest, 1980;66:314-322.
12. Welkos SL, Toskes PP, Baer H. Importance of anaerobic bacteria in the cobalamin malabsorption of the experimental rat blind loop syndrome. Gastroenterology, 1981;80:313-320.
13. Shindo K, Machida M, Koide K, et al. Deconjugation ability of bacteria isolated from the jejunal fluid of patients with progressive systemic sclerosis and its gastric pH. Hepatogastroenterology, 1998;45:1643-1650.
14. Tabaqchali S, Hatzioannou J, Booth CC. Bile-salt deconjugation and steatorhoea in patients with the stagnant-loop syndrome. Lancet, 1968;2:12-16.
15. Oumi M, Yamamoto T. A scanning electron microscope study on the effects of different bile salts on the epithelial lining of jejunal mucosa. Med Electron Microsc, 2000;33:11-15.
16. Giannella RA, Rout WR, Toskes PP. Jejunal brush border injury and impaired sugar and amino acid uptake in the blind loop syndrome. Gastroenterology, 1974;67:965-974.
17. Sherman P, Wesley A, Forstner G. Sequential disaccharidase loss in rat intestinal blind loops: impact of malnutrition. Am J Physiol, 1985;248:G626-G632.
18. King CE, Toskes PP. Protein-losing enteropathy in the human and experimental rat blind-loop syndrome. Gastroenterology, 1981;80:504-509.
19. Rutgeerts L, Mainguet P, Tytgat G, Eggermont E. Enterokinase in contaminated small-bowel syndrome. Digestion, 1974;10:249-254.
20. Stotzer PO, Bjornsson ES, Abrahamsson H. Interdigestive and postprandial motility in small-intestinal bacterial overgrowth. Scand J Gastroenterol, 1996;31:875-880.
21. Vantrappen G, Janssens J, Hellemans J, Ghoos Y. The interdigestive motor complex of normal subjects and patients with bacterial overgrowth of the small intestine. J Clin Invest, 1977;59:1158-1166.
22. Fich A, Steadman CJ, Phillips SF, et al. Ileocolonic transit does not change after right hemicolectomy. Gastroenterology, 1992;103:794-799.
23. Holt P. Diarrhea and malabsorption in the elderly. Gastroenterol Clin North Am, 2001;30:427-444.
24. Finegold SM, Sutter VL. Fecal flora in different populations, with special reference to diet. Am J Clin Nutr, 1978;31:S116-S122.
25. Collins MD, Gibson GR. Probiotics, prebiotics, and synbiotics: approaches for modulating the microbial ecology of the gut. Am J Clin Nutr, 1999;69:1052S-1057S.
26. Castiglione F, Rispo A, Di Girolamo E, et al. Antibiotic treatment of small bowel intestinal overgrowth in patients with Crohn's disease. Aliment Pharmacol Ther, 2003;18:1107-1112.
27. Mishkin D, Boston FM, Blank D, et al. The glucose breath test: a diagnostic test for small bowel stricture(s) in Crohn's disease. Dig Dis Sci, 2002;47:489-494.
28. Castiglione F, Del Vecchio Blancho G, Rispo A, et al. Orocaecal transit time and bacterial overgrowth in patients with Crohn's disease. J Clin Gastroenterol, 2000;31:63-66.
29. Lisowska A, Banasiewicz T, Marciniak R, et al. Chronic pouchitis is not related to small intestine bacterial overgrowth. Inflamm Bowel Dis, 2008;14:1102-1104.
30. Tursi A, Brandimarte G, Giorgetti G. High prevalence of small intestinal bacterial overgrowth in celiac patients with persistence of gastrointestinal symptoms after gluten withdrawal. Am J Gastroenterol, 2003;98:839-843.
31. Leffler DA, Dennis M, Hyett B, et al. Etiologies and predictors in nonresponsive celiac disease. Clin Gastroenterol Hepatol, 2007;5:445-450.
32. Strid H, Simren M, Stotzer PO, et al. Delay in gastric emptying in patients with chronic renal failure. Scand J Gastroenterol, 2004;39:516-520.
33. Strid H, Simren M, Stotzer PO, et al. Patients with chronic renal failure have abnormal small intestinal motility and a high prevalence of small intestinal bacterial overgrowth. Digestion, 2003;67:129-137.
34. Adachi H, Kamiya T, Hirako M, et al. Improvement of gastric motility by hemodialysis in patients with chronic renal failure. J Smooth Muscle Res, 2007;43:179-189.
35. Gunnarsdottir SA, Sadik R, Shev S, et al. Small intestinal motility disturbances and bacterial overgrowth in patients with liver cirrhosis and portal hypertension. Am J Gastroenterol, 2003;98:1362-1370.
36. Bauer TM, Steinbruckner B, Brinkmann FE, et al. Small intestinal bacterial overgrowth in patients with cirrhosis: prevalence and relation with spontaneous bacterial peritonitis. Am J Gastroenterol, 2001;96:2962-2967.
37. Sabate JM, Jouet P, Hanrois F, et al. High prevalence of small intestinal bacterial overgrowth in patients with morbid obesity: a contributor to severe hepatic steatosis. Obes Surg, 2008;18:371-377.
38. Gunnarsdottir SA, Sadik R, Shev S, et al. Small intestinal motility disturbances and bacterial overgrowth in patients with liver cirrhosis and portal hypertension. Am J Gastroenterol, 2003;98:1362-1370.
39. Soza A, Riquelme A, Gonzalez R, et al. Increased orocecal transit time in patients with nonalcoholic fatty liver disease. Dig Dis Sci, 2005;1136-1140.
40. Trespi E, Ferrieri A. Intestinal bacterial overgrowth during chronic pancreatitis. Curr Med Res Opin, 1999;15:47-52.
41. Van Felius ID, Akkermans LM, Bosscha K, et al. Interdigestive small bowel motility and duodenal bacterial overgrowth in experimental acute pancreatitis. Neurogastroenterol Motil, 2003;15:267-276.
42. Casellas F, Guarner L, Vaquero E, et al. Hydrogen breath test with glucose in exocrine pancreatic insufficiency. Pancreas, 1998;16:481-486.
43. Virally-Monod M, Tielmans D, Kevorkian JP, et al. Chronic diarrhea and diabetes mellitus: prevalence of small intestinal bacterial overgrowth. Diabetes Metab, 1998;43:2373-2378.
44. Reddymasu S, Sarosiek I, Sostarich S, McCallum R. Incidence and predictors of small intestinal bacterial overgrowth in gastroparesis. Gastroenterology, 2008;134:A97
45. Zietz B, Lock G, Straub RH, et al. Small-bowel bacterial overgrowth in diabetic subjects is associated with cardiovascular autonomic neuropathy. Diabetes Care, 2000;23:1200-1201.
46. Cuoco L, Montalto M, Jorizzo RA, et al. Eradication of small intestinal bacterial overgrowth and oro-cecal transit in diabetics. Hepato-Gastroenterol, 2002;49:1582-1586.
47. Lin HC. Small intestinal bacterial overgrowth: a framework for understanding irritable bowel syndrome. JAMA, 2004;292:852-858.
48. Posserud I, Stotazer PO, Bjornsson ES, et al. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Gut, 2007;56:802-808.
49. Pimentel M, Chow EJ, Lin HC. Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J Gastroenterol, 2000;95:3503-3506.
50. Pimentel M, Park S, Mirocha J, et al. The effect of a nonabsorbed oral antibiotic (rifaximin) on the symptoms of the irritable bowel syndrome: a randomized trial. Ann Intern Med, 2006 17;145:557-563.
51. DiBaise JK, Young RJ, Vanderhoof JA. Enteric microbial flora, bacterial overgrowth and short bowel syndrome. Clin Gastroenterol Hepatol, 2006;4:11-20.
52. Husebye E, Skar V, Hoverstad T, et al. Abnormal intestinal motor patterns explain enteric colonization with Gram-negative bacilli in late radiation enteropathy. Gastroenterology, 1995;109:1078-1089.
53. Pignata C, Budillon G, Monaco G, et al. Jejunal bacterial overgrowth and intestinal permeability in children with immunodeficiency syndromes. Gut, 1990;31:879-882.
54. Rubio-Tapia A, Herández-Calleros J, Trinidad-Hernández S, Uscanga L. Clinical characteristics of a group of adults with nodular lymphoid hyperplasia: a single center experience. World J Gastroenterol, 2006;28:1945-1948.
55. Riordan SM, McIver CJ, Walker BM, et al. The lactulose breath hydrogen test and small intestinal bacterial overgrowth. Am J Gastroenterol, 1996;91:1795-1803.
56. Kerlin P, Wong L. Breath hydrogen testing in bacterial overgrowth of the small intestine. Gastroenterology, 1988;95:982-988.
57. Riordan SM, McIver CJ, Bolin TD, Duncombe VM. Fasting breath hydrogen concentrations in gastric and small-intestinal bacterial overgrowth. Scand J Gastroenterol, 1995;30:252-257.
58. Sellin JH, Hart R. Glucose malabsorption associated with rapid intestinal transit. Am J Gastroenterol, 1992;87:584-589.
59. Romagnuolo J, Schiller D, Bailey RJ. Using breath tests wisely in a gastroenterology practice: an evidence-based review of indications and pitfalls in interpretation. Am J Gastroenterol, 2002; 97:1113-1126.
60. Schiller LR. Evaluation of small bowel bacterial overgrowth. Curr Gastroenterol Rep, 2007;9:373-377.
61. King CE, Toskes PP, et al. Comparison of the 1-gram [14C]xylose, 10-gram lactulose-H2, and 80-gram glucose-H2 breath tests in patients with small intestine bacterial overgrowth. Gastroenterology, 1986;91:1447-1451.
62. Riordan SM, McIver CJ, Duncombe VM, et al. Factors influencing the 1-g 14C-D-xylose breath test for bacterial overgrowth. Am J Gastroenterol, 1995;90:1455-1460.
63. Kirsch M. Bacterial overgrowth. Am J Gastroenterol, 1990;85: 231-237.
64. Watson WS, McKenzie I, Holden RJ, et al. An evaluation of the 14C-glycocholic acid breath test in the diagnosis of bacterial colonisation of the jejunum. Scott Med J, 1980;25:27-32.
65. Riordan SM, McIver CJ, Duncombe VM, Bolin TD. Bacteriologic analysis of mucosal biopsy specimens for detecting small-intestinal bacterial overgrowth. Scand J Gastroenterol, 1995;30:681-685.
66. Khoshini R, Dai SC, Lezcano S, Pimentel M. A systematic review of diagnostic tests for small intestinal bacterial overgrowth. Dig Dis Sci, 2007;8:1443-1454.
67. Fried M, Siegrist H, Frei R, et al. Duodenal bacterial overgrowth during treatment in outpatients with omeprazole. Gut, 1994;35:23-26.
68. Pardo A, Baroli R, Lorenzo-Zuniga V, et al. Effect of cisapride on intestinal bacterial overgrowth and bacterial translocation in cirrhosis. Hepatology, 2000;31:858-863.
69. Soudah HC, Hasler WL, Owyang C. Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma. NEJM, 1991;325:1461-1467.
70. Bouhnik Y, Alain S, Attar A, et al. Bacterial populations contaminating the upper gut in patients with small intestinal bacterial overgrowth syndrome. Am J Gastroenterol, 1999;94:1327-1331.
71. Attar A, Flourie B, Rambaud JC, et al. Antibiotic efficacy in small intestinal bacterial overgrowth-related chronic diarrhea: a crossover, randomized trial. Gastroenterology, 1999;117:794-797.
72. Di Stefano M, Malservisi S, Veneto G, et al. Rifaximin versus chlortetracycline in the short-term treatment of small intestinal bacterial overgrowth. Ali Pharmacol Ther, 2000;12:551-556.
73. Lauritano EC, Gabrielli M, Scarpellini E, et al. Small intestinal bacterial overgrowth recurrence after antibiotic therapy. Am J Gastroenterol, 2008;103:2031-2035.
74. Stotzer PO, Blomberg L, Conway PL, et al. Probiotic treatment of small intestinal bacterial overgrowth by Lactobacillus fermentum KLD. Scan J Infect Dis, 1996;28:1892-1901.